Trillium Therapeutics
IPOPublic · Toronto, Canada · Founded 1996 · $1.0M raised
- Headquarters
- Toronto
- Employees
- 51–200
- Founded
- 1996
- Business Model
- B2B
- Website
- trilliumtherapeutics.com
- Total Funding
- $1.0M
- Last Round
- $1.0M Venture RoundMay 2011
- Rounds
- 1
- Type
- Public
About
Trillium Therapeutics was a clinical-stage immuno-oncology company developing innovative cancer therapies, including fusion proteins targeting CD47, the 'don't eat me' signal used by cancer cells to evade macrophage-mediated killing. Founded in 1996 and publicly traded on NASDAQ and TSX (ticker: TRIL), the company was headquartered in Toronto, Canada with a Cambridge, MA research presence. Pfizer acquired Trillium in 2021 for approximately $2.26 billion to gain access to its two clinical-stage anti-CD47 assets.
Summary
Trillium Therapeutics is a Biotech company based in Toronto, Canada, founded in 1996. It has raised $1.0M in total across 1 round, most recently a $1.0M Venture Round round in May 2011. Investors include Pfizer Ventures.
Funding History
Aug 2021
Sign up to see all 2 rounds
Venture Round through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/trillium-therapeutics"><img src="https://indexed.vc/api/badge/company/trillium-therapeutics" alt="Trillium Therapeutics on Indexed.vc" width="260" height="76" /></a>